CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.
November 7th 2024
As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.
Copiktra Plus Chemotherapy Needs Further Study of Toxicities in Patients With CLL
September 2nd 2020An early phase 1b/2 study of Copiktra in combination of standard of care shows how the treatment is active for patients with chronic lymphocytic leukemia but further study is needed to ensure it is an effective and safe alternative to standard of care.
The Importance of More Thoughtful Treatment Strategies in High-Risk CLL
July 2nd 2020“If I only have one tool to treat the disease, I will play with that tool in many different ways. But if I have access to four different tools, then I will give up tool (number) one if I don't feel it's working,” explained Dr. Mazyar Shadman of the Seattle Cancer Care Alliance, about his approach to treating high-risk chronic lymphocytic leukemia in an interview with CURE®.
Expert Breaks Down the Three Treatment Modalities Currently Being Investigated in CLL
June 30th 2020“There’s a lot of work to do in CLL,” said Dr. Mazyar Shadman about the treatments currently being investigated in CLL. “We have been very fortunate to be able to provide a lot of options to our patients, but we shouldn't forget that there's a long way to go.”
What Factors Play a Role in Determining Optimal First Line Treatment for Patients With CLL
June 26th 2020There are three things that should be considered when deciding what is the optimal treatment in the first line setting for patients with chronic lymphocytic leukemia (CLL), according to Dr. Mazyar Shadman.